Vitamin K2 Market Size Projected to Reach $919.07 million by 2034 | 12.93%

According to Straits Research, the global vitamin K2 market size was valued at $307.66 million in 2025 and is expected to grow from $347.44 million in 2026 to $919.07 million by 2034, registering a CAGR of 12.93% during the forecast period (2026–2034).

Vitamin K2 is a fat-soluble vitamin that plays a crucial role in calcium metabolism, supporting bone mineralization and cardiovascular health. It activates proteins that help direct calcium to bones and teeth while preventing its accumulation in arteries. K2 is commonly used in dietary supplements, functional foods, and fortified beverages. The market is driven by increasing demand for natural and plant-based supplements, expanding functional food applications, and rising interest in preventive and holistic healthcare solutions.

Market Dynamics

Rising prevalence of osteoporosis and cardiovascular diseases drives the global market

The global vitamin K2 market is being propelled by the increasing prevalence of osteoporosis and cardiovascular conditions worldwide. Factors such as aging populations, sedentary lifestyles, and poor dietary habits are elevating the risk of bone fractures and heart-related issues, driving interest in preventive nutrition.

• A 2025 study indicates that nearly 50% of women over 50 in the U.K. are expected to experience osteoporotic fractures during their remaining lifetime, significantly higher than men of the same age. Likewise, the 2025 American Heart Association “Heart Disease and Stroke Statistics” update reports that almost 47% of U.S. adults have high blood pressure, a major cardiovascular risk factor.

These developments are fueling growing demand for vitamin K2 supplements and fortified foods.

Growing partnerships between supplement brands and pharma companies create tremendous opportunities

The global vitamin K2 market is benefiting from expanding opportunities through partnerships between supplement brands and pharmaceutical companies. These collaborations aim to bridge scientific research with consumer awareness, helping brands effectively communicate the health benefits of vitamin K2.

• For instance, in 2025, Gnosis by Lesaffre sponsored the 7th Osteoporosis Congress in Padova, Italy, convening experts in nephrology, osteoporosis, and bone health to advance knowledge on vitamin K2.
• In 2025, Balchem launched a consumer-focused campaign for its K2VITAL ingredient after a successful trial with the FC Bayern Women’s football team, promoting bone and cardiovascular health.

Such initiatives underscore a growing trend of strategic collaborations that foster innovation and enhance consumer education in the vitamin K2 market.

Regional Analysis

North America remains the dominant region in the global vitamin K2 market, driven by rising health awareness and strong supplement consumption. The region benefits from well-established pharmaceutical and nutraceutical industries, with major players investing in R&D and innovative product launches. Partnerships between ingredient suppliers and supplement brands are accelerating the introduction of functional foods and fortified beverages. Moreover, regulatory support and growing consumer preference for preventive healthcare contribute to the consistent market growth, making North America a critical hub for vitamin K2 development and commercial adoption.

Market Segments

1. By Product
   1. MK-7
   2. MK-4
2. By Dosage Form
   1. Capsules/Tablets
   2. Softgels
   3. Liquid
   4. Others
3. By Source
   1. Natural
   2. Synthetic
4. By Indication
   1. Bone Health
   2. Heart Health
   3. Blood Clotting
   4. Others
5. By Application
   1. Health Supplements
   2. Functional Foods and Beverages
6. By Distribution Channel
   1. Offline
      1. Pharmacies & Drug Stores
      2. Hypermarkets/Supermarkets
      3. Others
   2. Online
7. By Regions
   1. North America
   2. Europe
   3. Asia-Pacific
   4. Latin America
   5. The Middle East and Africa